PRESTO 2: An International Survey to Evaluate Patients’ Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly

Introduction Real-world data evaluating patients’ injection experiences using the latest devices/formulations of the long-acting (LA) somatostatin analogs (SSAs) lanreotide Autogel/Depot (LAN; Somatuline®) and octreotide LA release (OCT; Sandostatin®) are limited. Methods PRESTO 2 was a 2020/2021 e-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Advances in therapy 2023-02, Vol.40 (2), p.671-690
Hauptverfasser: O’Toole, Dermot, Kunz, Pamela L., Webb, Susan M., Goldstein, Grace, Khawaja, Sheila, McDonnell, Mark, Boiziau, Sandra, Gueguen, Delphine, Houchard, Aude, Ribeiro-Oliveira, Antonio, Prebtani, Ally
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!